Document is current
Any future updates will be listed below
-
Authors
Piorecka, Vaclava https://orcid.org/0000-0002-7661-0660
Vejmola, Cestmir https://orcid.org/0000-0002-6434-5978
Peskova, Petra
Piorecky, Marek
Jiricek, Stanislav
Koudelka, Vlastimil
Griskova-Bulanova, Inga
Palenicek, Tomas https://orcid.org/0000-0002-3109-9539
- License Information
-
More Information
Article History
Received: 3 February 2025
Revised: 9 September 2025
Accepted: 10 October 2025
First Online: 21 November 2025
Competing interests
: Dr. T. Páleníček declares to have shares in “Psychedelická klinika s.r.o”, have founded “PSYRES - Psychedelic Research Foundation”, have shares in “Společnost pro podporu neurovědního výzkumu s.r.o”, and is involved in Compass Pathways trials with psilocybin. T. Páleníček is involved in MAPS clinical trials with MDMA and reports consulting fees from GH Research and CB21-Pharma outside the submitted work. All the other authors have nothing to disclose.
